Conferences CROI 2014
Other Infections
Hepatitis C Cascade Studies Show Gaps in Testing and Treatment
- Details
- Category: HCV Treatment
- Published on Wednesday, 28 May 2014 00:00
- Written by Liz Highleyman
About half of people with hepatitis C are aware of their infection but less than 10% have been successfully treated and achieved sustained virological response, according to a meta-analysis presented at the recent Conference on Retroviruses and Opportunistic Infections (CROI 2014). A related study found that among HIV/HCV coinfected people, 40% had been referred to hepatitis C care but only 4% were cured.
CROI 2014: How Fast Does Fibrosis Progress in Acute Hepatitis C Patients with and without HIV?
- Details
- Category: Acute Hepatitis C
- Published on Wednesday, 28 May 2014 00:00
- Written by Liz Highleyman
Liver disease was found to progress slowly in studies of both HIV negative people with newly acquired hepatitis C virus (HCV) and HIV/HCV coinfected people with acute HCV, according to a pair of studies presented at the recent Conference on Retroviruses and Opportunistic Infections.
CROI 2014: Vitamin D and Rosuvastatin Improve Bone Loss in People with HIV
- Details
- Category: Bone Loss
- Published on Tuesday, 08 April 2014 00:00
- Written by Liz Highleyman
A combination of high-dose vitamin D and calcium may help reduce bone loss after starting antiretroviral therapy (ART), according to a presentation at the Conference on Retroviruses and Opportunistic Infections (CROI 2014) last month in Boston. A related study found that rosuvastatin increased hip bone mineral density in HIV positive people on ART, though insulin resistance worsened.
Studies Shed Light on Hepatitis C Virus Sexual Transmission among Gay Men
- Details
- Category: HCV Sexual Transmission
- Published on Tuesday, 20 May 2014 00:00
- Written by Liz Highleyman
Hepatitis C virus (HCV) transmission among HIV positive gay men has leveled off in Amsterdam -- one of the first cities with an outbreak of apparently sexually transmitted HCV infection -- and it continues to be rare among HIV negative men who have sex with men, according to recent studies. Other research looked at HCV sexual transmission among HIV positive and negative men in Switzerland, and at the association between HCV viral load in blood and semen.
CROI 2014: Tenofovir Alone May Work as Well as Truvada for Pre-exposure Prophylaxis
- Details
- Category: Pre-exposure Prophylaxis (PrEP)
- Published on Tuesday, 08 April 2014 00:00
- Written by Liz Highleyman
Tenofovir used as a single agent for pre-exposure prophylaxis (PrEP) may be as effective as the Truvada (tenofovir/emtricitabine) coformulation for preventing HIV infection, which, if confirmed, could have implications for cost and access worldwide.
CROI 2014 & EASL 2014: Treating Hepatitis B and C in HIV+ People Reduces Liver Disease
- Details
- Category: HCV Treatment
- Published on Monday, 12 May 2014 00:00
- Written by Liz Highleyman
Effective antiviral treatment that suppresses hepatitis B virus (HBV) repliaction or eradicates hepatitis C virus (HCV) can lower the risk of developing advanced liver disease including cirrhosis, hepatocellular carcinoma, and decompensation in people with HIV and viral hepatitis coinfection, according to studies presented at the recent Conference on Retroviruses and Opportunistic Infections (CROI) and EASL International Liver Congress.
CROI 2014: Neurocognitive Problems, Depression, and Early ART in People with HIV
- Details
- Category: Neurocognitive Problems
- Published on Tuesday, 08 April 2014 00:00
- Written by Matt Sharp
In a particularly challenging area of HIV care where research is complicated by gaps in knowledge and invasive clinical procedures, there was significant attention to neurological manifestations -- or neuroAIDS -- at this year’s Conference on Antiretroviral Agents and Chemotherapy (CROI 2014) last month in Boston.
CROI 2014: Chronic Lung Disease Is Prevalent and Under-diagnosed in People with HIV
- Details
- Category: HIV-Related Conditions
- Published on Friday, 25 April 2014 00:00
- Written by Theo Smart
Even though the incidence of most HIV-related respiratory complications and opportunistic infections have declined dramatically since the advent of effective antiretroviral therapy (ART), 4 studies presented at the 21st Conference on Retroviruses and Opportunistic Infections (CROI) last month in Boston showed that people living with HIV are still at increased risk of serious progressive lung complications, including under-diagnosed chronic obstructive pulmonary disease (COPD) and emphysema.
CROI 2014: Researchers Discuss HIV, Aging, and Frailty
- Details
- Category: HIV-Related Conditions
- Published on Friday, 04 April 2014 00:00
- Written by Theo Smart
People living with HIV are at greater risk of geriatric syndromes such as frailty and difficulty with daily activities than HIV negative people of the same age -- and this can have a significant effect upon their quality of life as they age, according to several studies presented at the 14th Conference on Retroviruses and Opportunistic Infections (CROI 2014) last month in Boston.
More Articles...
- CROI 2014: STIs Increase Risk of HIV Infection During Pregnancy
- CROI 2014: Self-Reports Did Not Reflect Actual Gel or Pill Use in VOICE PrEP Trial
- CROI 2014: Cumulative Viral Load and HIV Disease Progression
- CROI 2014: Women with Circumcised Partners Less Likely to Have HIV
- Advances in Hepatitis C Treatment: the Future Is Now [VIDEO]
- CROI 2014: Interferon-free BMS Combo Cures 90% of Genotype 1 Hepatitis C
- CROI 2014: Heart Attack Link to Abacavir Persists in D:A:D Study
- CROI 2014: Depo-Provera Contraceptive Linked to HIV Acquisition [VIDEO]
- CROI 2014: Very Different Levels of PrEP Uptake and Adherence in 3 U.S. Cities
- CROI 2014/APASL 2014: Merck Combo Suppresses HCV in Monoinfected and Coinfected Patients
- CROI 2014: Newborns Exposed to Tenofovir Have Lower Bone Content [VIDEO]
- CROI 2014: New Drugs, Novel Combos Top Tuberculosis News at Conference
- CROI 2014: Dapivirine Vaginal Ring Appears Safe and Effective in Tissue Study
- CROI 2014: Efavirenz Matches Lopinavir/ritonavir for Perinatal HIV Treatment
- CROI 2014: Lopinavir or Lamivudine Equally Protective Against HIV During Breast-feeding
- CROI 2014: People with HIV More Likely to Die of Many Common Cancers
- CROI 2014: Nipping HIV in the Bud -- Could We Use Genotyping to Interrupt Transmission?
- CROI 2014: Disparities in Viral Suppression in Washington, DC [VIDEO]
- CROI 2014: Heart Attack Risk May Be Falling for People with HIV -- But Not for Women
- CROI 2014: Raltegravir Has Edge Over 2 HIV Protease inhibitors in 3-Drug Comparison
- CROI 2014: Early Treatment Reduces Viral Reservoirs but Does Not Prevent Rebound
- CROI 2014: Early Antiretroviral Therapy May Limit Gut Damage and Immune Activation
- CROI 2014: Natural History of HIV-Related Anal Dysplasia [VIDEO]
- CROI 2014: Daclatasvir + Simeprevir Effective Against Hepatitis C Genotype 1b
- CROI 2014: HIV Incidence at Record High Among Young Gay Black Men in Southern U.S.
- CROI 2014: Maternal Deaths Due to HIV Not Declining Despite PMTCT Successes In South Africa
- CROI 2014: New NNRTI Doravirine Matches Efavirenz for First-line HIV Treatment
- CROI 2014: Novel 2-Drug Maintenance Combo Works Well, Stage Set for Long-lasting Injectables
- CROI 2014: Long-Acting HIV Drugs for Maintenance Therapy [VIDEO]
- CROI 2014: Raltegravir Works as Well as Tenofovir for HIV Treatment [VIDEO]
- CROI 2014: Boston Patients Experience HIV Rebound after Stem Cell Transplants
- CROI 2014: HIV Rebounds in Boston Bone Marrow Transplant Patients [VIDEO]
- CROI 2014: Protected T-cells Persist and Proliferate in HIV Gene Therapy Study
- CROI 2014: HIV Cure News from the Retrovirus Conference
- CROI 2014: Monkey Studies Confirm Validity of Injectable PrEP
- CROI 2014: Depression and HIV are Risk Factors for Heart Failure Among Veterans
- CROI 2014: Tesamorelin Growth-Hormone Releaser Reduces Liver Fat in People with HIV
- CROI 2014: Men Not Benefiting as Much as Women from HIV Treatment in Africa [VIDEO]
- CROI 2014: Raltegravir Plus Boosted Darunavir Is Safe and Effective for First-line ART
- CROI 2014: HIV Transmission through Condomless Sex [VIDEO]
- CROI 2014: HIV Treatment as Prevention Works in PARTNER Study
- CROI 2014: Long-acting GSK744 Protects Monkeys against HIV-like Virus [VIDEO]
- CROI 2014: Mississippi Child Remains Free of HIV [VIDEO]
- CROI 2014: HIV Attachment Inhibitor BMS-663068 Shows Good Safety and Efficacy in Phase 2b
- CROI 2014: Simeprevir Cures Almost 80% of First-time HIV/HCV Coinfected Patients
- CROI 2014: AbbVie 3D Combination Cures 99% of Genotype 1b Hepatitis C
- CROI 2014: Short 6-Week Oral Treatment Works for Most Hepatitis C Patients
- CROI 2014: Faldaprevir + Interferon Cures HIV/HCV Coinfected People
- CROI 2014: HIV Cure May Need Multiple Components, Workshop Delegates Hear
- CROI 2014: Treatment as Prevention Dramatically Lowers HIV Sexual Transmission [VIDEO]
- CROI 2014: No One with Undetectable Viral Load Transmits HIV in PARTNER Study
- CROI 2014: Sofosbuvir + Ribavirin Cures 75% of Genotype 1 HIV/HCV Coinfected Patients
- CROI 2014: Retrovirus Conference Now Underway in Boston
- CROI 2014: The Role of Interferon in HIV Response [VIDEO]
- CROI 2014: Hepatitis C Treatment in the Real World [VIDEO]
- CROI 2014: HIV in People Who Use Drugs [VIDEO]
- CROI 2014: Retrovirus Conference Starts Monday in Boston
Web Design and Development by